<DOC>
	<DOCNO>NCT02112747</DOCNO>
	<brief_summary>This randomize clinical trial study website access genetic counseling without patient navigator adherence colorectal cancer screen recommendation patient newly diagnose colorectal cancer first degree relative . Websites colorectal cancer prevention genetic counseling may effective method help people learn cancer screening . Patient navigator may improve adherence colorectal cancer screen recommendation . It yet know whether website access genetic counseling effective without patient navigator .</brief_summary>
	<brief_title>Adherence Colon Cancer Screening ( ACCS )</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Test comparative-effectiveness intervention ( i.e. , website +/- navigator genetic counseling +/- navigator ) randomize control trial , use colorectal cancer ( CRC ) case unit randomization/analysis adherence individualize CRC screen recommendation . SECONDARY OBJECTIVES : I . Examine cost effectiveness intervention , assess effect intervention subgroup ( i.e. , Lynch syndrome positive vs. Lynch syndrome negative ; probands vs. relative ; old vs. young patient , etc ) , barrier adherence , well navigator resolve barrier . II . Overscreening explored . OUTLINE : Participants assign 1 2 study component base LS status . Within component , participant randomize 1 2 arm . COMPONENT # 1 ( Lynch Negative Proband first degree relative ( FDRs ) : ARM I : Participants access website deliver `` personalized prescription CRC prevention '' base age , Lynch Syndrome status , cancer history , age 1st degree relative CRC , personal CRC screen history . ARM II : Participants access website Arm I receive service patient navigator address individual barrier adhere `` personal prescription '' within 1 month . COMPONENT # 2 ( Lynch Positive Proband FDRs ) : ARM III ( Lynch positive proband ) : Participants use genetic counseling discus medical family history genetic risk CRC , include genetic factor deoxyribonucleic acid ( DNA ) mismatch repair gene , autosomal dominant inheritance , cancer risk associate LS , screen recommendation , genetic testing . ARM IV ( Lynch positive proband ) : Participants use genetic counseling Arm III receive service patient navigator address individual barrier adhere CRC screen recommendation within 1 month . After completion study treatment , patient follow 12-14 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Newly diagnose colorectal adenocarcinoma Ohio State University ( OSU ) ( participate Ohio hospital ) sufficient tumor available perform microsatellite instability ( MSI ) test , regardless age diagnosis family history Firstdegree relatives case test positive LS Firstdegree relatives case test negative LS Pregnant woman Prisoners Individuals cognitively impair</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Colorectal Cancer Prevention</keyword>
	<keyword>Colorectal Cancer Screening</keyword>
	<keyword>ACCS</keyword>
	<keyword>Lynch Syndrome</keyword>
	<keyword>LS</keyword>
</DOC>